GlassScriptPhysician profile
Stephen K Schmitz
NPI 1871080598
$5,116.87
in general payments reported to CMS, 2019-2025
11 companies · $1,658 in 2025
The $1,658 reported for 2025 was more than what 80% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $172 · 2023: $2,001 · 2024: $1,286 · 2025: $1,658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,009 · Travel and Lodging: $936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,009.26 |
| Travel and Lodging | $935.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,336.06 | 2022-2025 | Augment Injectable, Prostep, Infinity Adaptis |
| Paratek Pharmaceuticals, INC. | $194.12 | 2023-2025 | Nuzyra |
| Biotissue Holdings INC. | $152.57 | 2023 | |
| Medtronic, INC. | $127.95 | 2024 | Intellis Adaptivestim |
| Abbott Laboratories | $80.00 | 2023 | Proclaim |
| Smith+Nephew, INC. | $59.35 | 2023-2024 | Bone Anchors With Arthroscopic Delivery System, Evos |
| Organogenesis INC. | $47.01 | 2025 | Simplimax |
| Kerecis Limited | $42.09 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Depuy Synthes Sales INC. | $32.18 | 2025 | Motoband |
| Pylant Medical | $29.00 | 2025 | |
| Treace Medical Concepts, INC. | $16.54 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Schmitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.